Come up with a name for your new list and we'll add to it:
Targanta Therapeutics raised a round of funding on February 26, 2009. Investors include
The Medicines Company.
Targanta Therapeutics, Inc. (NASDAQ:TARG) is a biotechnology company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Targanta's lead drug candid…